Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Simple gel may shield cancer patients from painful side effect

NCT ID NCT07177560

First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 27 times

Summary

This study looked at whether applying a diclofenac gel (a common anti-inflammatory) to the hands and feet can prevent or delay hand-foot syndrome—a painful skin reaction—in people with colorectal or stomach cancer taking the chemotherapy drug capecitabine. About 150 patients were followed at two cancer centers in Turkey. The goal was to see if the gel reduces the number of patients who develop severe skin problems and helps them stay on their cancer treatment longer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Ankara Etlik City Hospital

    Ankara, Turkey (Türkiye)

  • Gazi University

    Ankara, Turkey (Türkiye)

Conditions

Explore the condition pages connected to this study.